Article Details

Innovent Biologics Inc (IVBIY) Partners with Roche for Novel DLL3 Antibody Drug Conjugate

Retrieved on: 2025-01-02 00:03:24

Tags for this article:

Click the tags to see associated articles and topics

Innovent Biologics Inc (IVBIY) Partners with Roche for Novel DLL3 Antibody Drug Conjugate. View article details on hiswai:

Excerpt

Innovent has secured a strategic partnership with Roche, a global leader in oncology. IBI3009 has shown promising anti-tumor activity and a favorable ...

Article found on: www.gurufocus.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo